Acceleration of spinal fusion using COMP-angiopoietin 1 with allografting in a rat model

Bone

Volumn 49, Issue 3, 2011, Pages 447-454

  Park, Byung Hyun ^a   Song, Kyung Jin ^a   Yoon, Sun Jung ^a   Park, Ho Sung ^a   Jang, Kyu Yun ^a   Zhou, Lu ^a   Lee, Sang Yong ^a   Lee, Kwang Bok ^a   Kim, Jung Ryul ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Angiogenesis; Arthrodesis; COMP Ang1; Osteogenesis; Spine

Indexed keywords

ANGIOPOIETIN 1; BLOOD CLOTTING FACTOR 8; BOVINE SERUM ALBUMIN; CARTILAGE OLIGOMERIC MATRIX PROTEIN; COLLAGEN SPONGE; RNA; TRANSCRIPTION FACTOR RUNX2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRODESIS; ARTICLE; BIOMECHANICS; BONE ALLOGRAFT; BONE DEVELOPMENT; BONE STRENGTH; BONE TRANSPLANTATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE TARGETING; IMMUNOHISTOCHEMISTRY; MALE; MEDICAL ASSESSMENT; MORPHOMETRICS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPTICAL DENSITY; PALPATION; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINE FUSION; SPINE RADIOGRAPHY; UPREGULATION;

ANGIOPOIETIN-1; ANIMALS; CATTLE; LUMBAR VERTEBRAE; MALE; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; SPINAL FUSION; TRANSPLANTATION, HOMOLOGOUS; X-RAY MICROTOMOGRAPHY;

EID: 79960574497     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.05.020     Document Type: Article

References (48)

1. Sandhu H.S., Grewal H.S., Parvataneni H. Bone grafting for spinal fusion. Orthop Clin North Am 1999, 30:685-698.
2. Sawin P.D., Traynelis V.C., Menezes A.H. A comparative analysis of fusion rates and donor-site morbidity for autogeneic rib and iliac crest bone grafts in posterior cervical fusions. J Neurosurg 1998, 88:255-265.
3. Herkowitz H.N., Kurz L.T. Degenerative lumbar spondylolisthesis with spinal stenosis. A prospective study comparing decompression with decompression and intertransverse process arthrodesis. J Bone Joint Surg Am 1991, 73:802-808.
4. Boden S.D. Biology of lumbar spine fusion and use of bone graft substitutes: present, future, and next generation. Tissue Eng 2000, 6:383-399.
5. Fischgrund J.S., Mackay M., Herkowitz H.N., Brower R., Montgomery D.M., Kurz L.T. Volvo Award winner in clinical studies. Degenerative lumbar spondylolisthesis with spinal stenosis: a prospective, randomized study comparing decompressive laminectomy and arthrodesis with and without spinal instrumentation. Spine 1997, 22:2807-2812.
6. Winet H. The role of microvasculature in normal and perturbed bone healing as revealed by intravital microscopy. Bone 1996, 19:39S-57S.
7. Carano R.A., Filvaroff E.H. Angiogenesis and bone repair. Drug Discov Today 2003, 8:980-989.
8. Gerber H.P., Ferrara N. Angiogenesis and bone growth. Trends Cardiovasc Med 2000, 10:223-228.
9. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000, 407:242-248.
10. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996, 87:1171-1180.
11. Suri C., McClain J., Thurston G., McDonald D.M., Zhou H., Oldmixon E.H., et al. Increased vascularization in mice overexpressing angiopoietin-1. Science 1998, 282:468-471.
12. Cho C.H., Kammerer R.A., Lee H.J., Yasunaga K., Kim K.T., Choi H.H., et al. Designed angiopoietin-1 variant, COMP-Ang1, protects against radiation-induced endothelial cell apoptosis. Proc Natl Acad Sci U S A 2004, 101:5553-5558.
13. Cho C.H., Kim K.E., Byun J., Jang H.S., Kim D.K., Baluk P., et al. Long-term and sustained COMP-Ang1 induces long-lasting vascular enlargement and enhanced blood flow. Circ Res 2005, 97:86-94.
14. Boden S.D., Schimandle J.H., Hutton W.C. An experimental lumbar intertransverse process spinal fusion model. Radiographic, histologic, and biomechanical healing characteristics. Spine 1995, 20:412-420.
15. Schimandle J.H., Boden S.D., Hutton W.C. Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine 1995, 20:1326-1337.
16. Morone M.A., Boden S.D. Experimental posterolateral lumbar spinal fusion with a demineralized bone matrix gel. Spine 1998, 23:159-167.
17. Glassman S.D., Carreon L.Y., Djurasovic M., Campbell M.J., Puno R.M., Johnson J.R., et al. RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age. Spine 2008, 33:2843-2849.
18. Burkus J.K., Schuler T.C., Gornet M.F., Zdeblick T.A. Anterior lumbar interbody fusion for the management of chronic lower back pain: current strategies and concepts. Orthop Clin North Am 2004, 35:25-32.
19. Weinstein J.N., Lurie J.D., Tosteson T.D., Hanscom B., Tosteson A.N., Blood E.A., et al. Surgical versus nonsurgical treatment for lumbar degenerative spondylolisthesis. N Engl J Med 2007, 356:2257-2270.
20. Colterjohn N.R., Bednar D.A. Procurement of bone graft from the iliac crest. An operative approach with decreased morbidity. J Bone Joint Surg Am 1997, 79:756-759.
21. Hill N.M., Horne J.G., Devane P.A. Donor site morbidity in the iliac crest bone graft. Aust N Z J Surg 1999, 69:726-728.
22. Robertson P.A., Wray A.C. Natural history of posterior iliac crest bone graft donation for spinal surgery: a prospective analysis of morbidity. Spine 2001, 26:1473-1476.
23. Choi Y., Oldenburg F.P., Sage L., Johnstone B., Yoo J.U. A bridging demineralized bone implant facilitates posterolateral lumbar fusion in New Zealand white rabbits. Spine 2007, 32:36-41.
24. Itoh H., Ebara S., Kamimura M., Tateiwa Y., Kinoshita T., Yuzawa Y., et al. Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2. Spine 1999, 24:1402-1405.
25. Davis S., Aldrich T.H., Jones P.F., Acheson A., Compton D.L., Jain V., et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996, 87:1161-1169.
26. Saharinen P., Kerkela K., Ekman N., Marron M., Brindle N., Lee G.M., et al. Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2. J Cell Biol 2005, 169:239-243.
27. Thurston G., Suri C., Smith K., McClain J., Sato T.N., Yancopoulos G.D., et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999, 286:2511-2514.
28. Thurston G., Rudge J.S., Ioffe E., Zhou H., Ross L., Croll S.D., et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000, 6:460-463.
29. Cho C.H., Sung H.K., Kim K.T., Cheon H.G., Oh G.T., Hong H.J., et al. COMP-angiopoietin-1 promotes wound healing through enhanced angiogenesis, lymphangiogenesis, and blood flow in a diabetic mouse model. Proc Natl Acad Sci U S A 2006, 103:4946-4951.
30. Kim W., Moon S.O., Lee S.Y., Jang K.Y., Cho C.H., Koh G.Y., et al. COMP-angiopoietin-1 ameliorates renal fibrosis in a unilateral ureteral obstruction model. J Am Soc Nephrol 2006, 17:2474-2483.
31. Lee S., Kim W., Moon S.O., Sung M.J., Kim D.H., Kang K.P., et al. Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes. Nephrol Dial Transplant 2007, 22:396-408.
32. Park B.H., Jang K.Y., Kim K.H., Song K.H., Lee S.Y., Yoon S.J., et al. COMP-angiopoietin-1 ameliorates surgery-induced ischemic necrosis of the femoral head in rats. Bone 2009, 44:886-892.
33. Park B.H., Yoon S.J., Jang K.Y., Kim M.R., Lee H.S., Kim K.B., et al. COMP-angiopoietin-1 accelerates bone formation during distraction osteogenesis. Bone 2010, 46:1442-1448.
34. Isner J.M., Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 1999, 103:1231-1236.
35. Suzuki T., Miyamoto T., Fujita N., Ninomiya K., Iwasaki R., Toyama Y., et al. Osteoblast-specific Angiopoietin 1 overexpression increases bone mass. Biochem Biophys Res Commun 2007, 362:1019-1025.
36. Street J., Bao M., deGuzman L., Bunting S., Peale F.V., Ferrara N., et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A 2002, 99:9656-9661.
37. Fang T.D., Salim A., Xia W., Nacamuli R.P., Guccione S., Song H.M., et al. Angiogenesis is required for successful bone induction during distraction osteogenesis. J Bone Miner Res 2005, 20:1114-1124.
38. Miyazaki M., Morishita Y., He W., Hu M., Sintuu C., Hymanson H.J., et al. A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats. Spine J 2009, 9:22-30.
39. Wang J.C., McDonough P.W., Endow K.K., Delamarter R.B. Increased fusion rates with cervical plating for two-level anterior cervical discectomy and fusion. Spine 2000, 25:41-45.
40. Johnson J.S., Meliton V., Kim W.K., Lee K.B., Wang J.C., Nguyen K., et al. Novel oxysterols have pro-osteogenic and anti-adipogenic effects in vitro and induce spinal fusion in vivo. J Cell Biochem 2011, 112:1673-1684.
41. Taghavi C.E., Lee K.B., He W., Keorochana G., Murray S.S., Brochmann E.J., et al. Bone morphogenetic protein binding peptide mechanism and enhancement of osteogenic protein-1 induced bone healing. Spine 2010, 35:2049-2056.
42. Komori T. Regulation of skeletal development by the Runx family of transcription factors. J Cell Biochem 2005, 95:445-453.
43. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764.
44. Ducy P., Starbuck M., Priemel M., Shen J., Pinero G., Geoffroy V., et al. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 1999, 13:1025-1036.
45. Ducy P., Zhang R., Geoffroy V., Ridall A.L., Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997, 89:747-754.
46. Jeong B.C., Kim H.J., Bae I.H., Lee K.N., Lee K.Y., Oh W.M., et al. COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation. Bone 2010, 46:479-486.
47. Bais M.V., Wigner N., Young M., Toholka R., Graves D.T., Morgan E.F., et al. BMP2 is essential for post natal osteogenesis but not for recruitment of osteogenic stem cells. Bone 2009, 45:254-266.
48. Jeon E.J., Lee K.Y., Choi N.S., Lee M.H., Kim H.N., Jin Y.H., et al. Bone morphogenetic protein-2 stimulates Runx2 acetylation. J Biol Chem 2006, 281:16502-16511.